Dr. Hsieh Wen Son

Dr. Wen-son Hsieh is a specialist in the treatment of various types of cancers and is active in developing novel cancer diagnostics and molecularly targeted anti-cancer treatments. In addition, he serves as the Medical Director of International Cancer Specialists. His vision for International Cancer Specialists is to provide patient-centered, cutting edge cancer care that is affordable and compassionate.

Born in Taiwan, Dr. Hsieh grew up in the United States and was educated in the United States and the United Kingdom. He attended college at Tulane University in New Orleans, Louisiana, graduating summa cum laude with a degree in Neuroscience. He went on to study philosophy and psychology at Oxford University, England on a prestigious Rhodes Scholarship. He then completed his medical training at some of the top academic institutions in the World, including a medical degree from Johns Hopkins University School of Medicine, internship and residency in Internal Medicine at Duke University and a fellowship in medical oncology at Johns Hopkins. Dr. Hsieh is certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine.

After completion of his medical training, Dr. Hsieh was active in patient care, teaching, and research in his posts as Consultant in Medical Oncology, Johns Hopkins Singapore International Medical Center and Assistant Professor in Oncology, Johns Hopkins University School of Medicine.

Dr. Hsieh has been working in Singapore since 2001 and has been active in the treatment of patients and development of novel cancer therapies. With a research interest in molecularly targeted cancer therapies and immunotherapy, he has led a number of international studies involving centers in Singapore, Hong Kong, Korea, and the United States examining novel treatments for nasopharyngeal carcinoma. Dr. Hsieh has authored a number of scientific articles, abstracts, and book chapters and has lectured extensively at regional and international medical and scientific conferences. In addition, he has received a number of awards, including a Cure for Lymphoma Foundation fellowship and a Rhodes Scholarship